Haeggquist & Eck, LLP, a leading shareholder rights litigation firm, is investigating whether certain directors and officers of Envision Healthcare Corporation (“Envision” or the “Company”) (NYSE: EVHC) breached their fiduciary duties to the Company and its shareholders. If you are an Envision shareholder, you are encouraged to contact Haeggquist & Eck for additional information.

Envision and its EmCare subsidiary provide an array of healthcare-related services to consumers, hospitals, healthcare systems, health plans and local, state, and national government entities. With nearly 16,000 affiliated physicians and other clinicians, EmCare is the nation’s leading provider of integrated facility-based physician services.

On July 24, 2017, The New York Times published an article about EmCare titled, “The Company Behind Many Surprise Emergency Room Bills.” The article cited a recent study by Yale University researchers stating that hospitals associated with Envision’s EmCare were more likely to engage in “surprise billing,” where a patient seeking in-network care is treated by an out-of-network doctor, and thus billed at higher rates. The added costs were often passed on directly to patients.

An expert quoted in the article described this practice as a “kind of ambushing of patients,” since patients who need emergency room care can try to go to an in-network hospital, but usually cannot choose the specific doctor who treats them there. The Company failed to disclose these practices or the fact that its revenues were unlikely to be sustainable once the conduct came to light, rendering its public statements false and misleading.

What You Can Do

If you are an Envision shareholder, you may have legal claims against Envision’s directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please call attorney Amber Eck at 619-342-8000 or e-mail her at ambere@haelaw.com. There is no cost or obligation to you.

Haeggquist & Eck, LLP is a nationally recognized leader in shareholder rights law. The firm represents individual investors in shareholder derivative lawsuits, and members of the firm have helped shareholders recover more than $1 billion of value for themselves and the companies in which they have invested.

This release constitutes attorney advertising. Past results do not guarantee a similar outcome.